These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24189134)

  • 1. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
    Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
    Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
    Aggarwal R; Dewan A
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics.
    Burt D; Crowell SJ; Ackley DC; Magee TV; Aubrecht J
    Drug Chem Toxicol; 2014 Apr; 37(2):204-12. PubMed ID: 24128070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.
    Hoffmann D; Fuchs TC; Henzler T; Matheis KA; Herget T; Dekant W; Hewitt P; Mally A
    Toxicology; 2010 Nov; 277(1-3):49-58. PubMed ID: 20816719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
    Zavascki AP; Nation RL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
    Crass RL; Rutter WC; Burgess DR; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
    Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
    Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
    Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
    Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.
    Vlasakova K; Erdos Z; Troth SP; McNulty K; Chapeau-Campredon V; Mokrzycki N; Muniappa N; Gu YZ; Holder D; Bailey WJ; Sistare FD; Glaab WE
    Toxicol Sci; 2014 Mar; 138(1):3-20. PubMed ID: 24361871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
    Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells.
    Vaara M; Vaara T
    Int J Antimicrob Agents; 2013 Mar; 41(3):292-3. PubMed ID: 23182536
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymyxin B Nephrotoxicity: From Organ to Cell Damage.
    Vattimo Mde F; Watanabe M; da Fonseca CD; Neiva LB; Pessoa EA; Borges FT
    PLoS One; 2016; 11(8):e0161057. PubMed ID: 27532263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B.
    Li ZD; Luo J; Jia LH; Wang XY; Xun ZK; Liu M
    Hum Exp Toxicol; 2019 Feb; 38(2):193-200. PubMed ID: 30016892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
    Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
    Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of renal proximal tubule injury, reversal, and related biomarker changes in rats following cisplatin administration.
    McDuffie JE; Ma JY; Sablad M; Sonee M; Varacallo L; Louden C; Guy A; Vegas J; Liu X; La D; Snook S
    Int J Toxicol; 2013 Jul; 32(4):251-60. PubMed ID: 23788329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.
    Phe K; Lee Y; McDaneld PM; Prasad N; Yin T; Figueroa DA; Musick WL; Cottreau JM; Hu M; Tam VH
    Antimicrob Agents Chemother; 2014 May; 58(5):2740-6. PubMed ID: 24566187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid.
    Betton GR; Ennulat D; Hoffman D; Gautier JC; Harpur E; Pettit S
    Toxicol Pathol; 2012 Jun; 40(4):682-94. PubMed ID: 22301952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.